NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Influence of hemolysis on routine clinical chemistry testing.

Author(s): Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC

Publication: Clin Chem Lab Med, 2006, Vol. 44, Page 311-6

PubMed ID: 16519604 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of hemolysis on the measurement of common clinical chemistry analytes.

Conclusion of Paper

Hemolysis interference with the measurement of clinical chemistry analytes was generally linear and affected 17 of 20 analytes. Aspartate amino transferase (AST), chloride, lactate dehydrogenase (LDH), sodium, and potassium levels were the most affected by free serum hemoglobin. Calcium, total bilirubin, and glucose showed no clinically significant changes in specimens containing added levels of free hemoglobin compared to those with no hemolysis.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of hemolysis on the measurement of common clinical chemistry analytes. Hemolysis was achieved by subjecting whole blood to an overnight freeze-thaw cycle, mixing it with serum that was also frozen overnight (-70 degrees C), and subsequently using this mixture for serial dilution of fresh blood specimens. Resulting fresh serum specimens contained free hemoglobin levels between 0 and 20.6 g/L.

    Summary of Findings:

    As expected, subjecting whole blood to an overnight freeze-thaw cycle lowered white blood cell, platelet, and erythrocyte counts beyond the analytical sensitivity of the analyzer. Hemolysis interference with the measurement of clinical chemistry analytes was generally linear and led to overestimation of alanine amino transferase (ALT), creatinine, AST, creatine kinase (CK), iron, LDH, magnesium, potassium, lipase, phosphorus, and urea nitrogen and underestimation of albumin, alkaline phosphatase (ALP), chloride, gamma-glutamyltransferase (GGT), sodium, and uric acid. AST, chloride, LDH, sodium, and potassium levels were the most affected by free serum hemoglobin. Calcium, total bilirubin, and glucose showed no clinically significant changes in specimens containing added levels of free hemoglobin compared to those with no hemolysis.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Spectrophotometry
    Protein Clinical chemistry/auto analyzer
    Small molecule Clinical chemistry/auto analyzer
    Electrolyte/Metal Clinical chemistry/auto analyzer
    Carbohydrate Clinical chemistry/auto analyzer
    Protein Hematology/ auto analyzer
    Cell count/volume Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Biospecimen components 0 g/L serum hemoglobin
    0.16 g/L serum hemoglobin
    0.3 g/L serum hemoglobin
    0.6 g/L serum hemoglobin
    1.3 g/L serum hemoglobin
    2.6 g/L serum hemoglobin
    5.1 g/L serum hemoglobin
    10.3 g/L serum hemoglobin
    20.6 g/L serum hemoglobin
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Biospecimen Aliquots and Components Hemolysis Freeze/thaw-induced
    Hemolysate added
    No hemolysate added

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...